Elsevier

Neuroscience

Volume 62, Issue 3, October 1994, Pages 741-758
Neuroscience

Selective expression of clusterin (SGP-2) and complement C1qB and C4 during responses to neurotoxinsin vivo andin vitro

https://doi.org/10.1016/0306-4522(94)90473-1Get rights and content

Abstract

This study concerns expression of the genes encoding three multifunctional proteins: clusterin and two complement cascade components, C1q and C4. Previous work from this and other laboratories has established that clusterin, Clq and C4 messenger RNAs are elevated during Alzheimer's disease, and in response to deafferenting and excitotoxic brain lesions. This study addresses hippocampal clusterin, ClqB and C4 expression in response to neurotoxins that caused selective neuron death. Kainate, which preferentially kills hippocampal CA3 pyramidal neurons but not dentate gyrus granule neurons induced clusterin immunoreactivity in CA1 and CA3 pyramidal neurons and adjacent astrocytes, but not in dentate gyrus granule neurons. In contrast, colchicine, which preferentially kills the dentate gyrus granule neurons, induced clusterin immunoreactivity in the local neuropil as punctate deposits, but not in the surviving or degenerating dentate gyrus granule neurons. Clusterin messenger RNA was increased in astrocytes. C1qB and C4 messenger RNAs increased within 48 h after kainate injections, particularly in the CA3 pyramidal layer, less in the dentate gyrus-CA4, and less in CA1. C1q immunoreactivity was detected in CA1 pyramidal neurons and also as small punctate deposits in the CA1 region at eight and 14 days after kainate. The increase of both clusterin and C1qB messenger RNAs after kainate injections was blocked by barbiturates that prevented seizures and neurodegeneration. In primary hippocampal neuronal cultures treated with glutamate, a subpopulation of cultured neurons that survived glutamate toxicity also had parallel elevations of clusterin and C1qB messenger RNA.

In conclusion, cytotoxins that target selective hippocampal neurons increase the expression of both clusterin and C1qBin vivo andin vitro. These results show that elevations of clusterin messenger RNA or protein can be dissociated from each other and from cell death. These increased messenger RNAs were associated with immunoreactive deposits that differed by cell type and intra- versus extracellular locations. These results suggest that the complement system is involved in brain responses to injury.

Reference (83)

  • Lampert-EtchellsM. et al.

    Sulfated glycoprotein-2 is increased in rat hippocampus following entorhinal cortex lesioning

    Brain Res.

    (1991)
  • LegerJ.G. et al.

    Characterization and cloning of androgen-repressed mRNAs from rat ventral prostate

    Biochem. biophys. Res. Commun.

    (1987)
  • LynchG. et al.

    The nature and causes of hippocampal long-term potentiation

    Prog. Brain Res.

    (1990)
  • MayP.C. et al.

    Dynamics of gene expression for a rat hippocampal glycoprotein elevated in Alzheimer's disease and in response to experimental lesions in rat

    Neuron

    (1990)
  • MayP.C. et al.

    Sulfated glycoprotein-2: new relationship of this multifunctional protein to neurodegeneration

    Trends Neurosci.

    (1992)
  • MayP.C. et al.

    Sulfated glycoprotein-2 expression increases in rodent brain after transient global ischemia

    Molec. Brain Res.

    (1992)
  • McGeerP.L. et al.

    Activation of the classical complement pathway in brain tissue of Alzheimer patients

    Neurosci. Lett.

    (1989)
  • McGeerP.L. et al.

    Distribution of clusterin in Alzheimer brain tissue

    Brain Res.

    (1992)
  • McNeillT.H. et al.

    Effect of chronic adrenalectomy on neuron loss and distribution of sulfated glycoprotein-2 in the dentate gyrus of prepubertal rats

    Expl Nurol.

    (1991)
  • MorganT.E. et al.

    TGF-β1 mRNA increases in macrophage/microglial cells of the hippocampus in response to deaferentation and kainic acid-induced neurodegeneration

    Expl Nurol.

    (1993)
  • NadlerJ.V. et al.

    Comparative toxicity of kainic acid and other acidic amino acaids toward rat hippocampal neurons

    Neuroscience

    (1981)
  • PasinettiG.M. et al.

    Complement ClqB and C4 mRNAs responses to lesioning in rat brain

    Expl Nurol.

    (1992)
  • PerryV.H. et al.

    Immunohistochemical localization of macrophages and microglia in the adult and developing mouse brain

    Neuroscience

    (1985)
  • PoirierJ. et al.

    Astrocytic apolipoprotein E mRNA and GFAP mRNA in hippocampus after entorhinal cortex lesioning

    Molec. Brain Res.

    (1991)
  • PoirierJ. et al.

    Cholesterol synthesis and lipoprotein reuptake during synaptic remodelling in hippocampus in adult rats

    Neuroscience

    (1993)
  • RichterJ.A. et al.

    Barbituates: theirin vivo effects and potential biochemical mechanisms

    Prog. Neurobiol.

    (1982)
  • SchreiberS.S. et al.

    Seizure activity causes a rapid increase in sulfated glycoprotein-2 messenger RNA in the adult but not the neonatal rat brain

    Neurosci. Lett.

    (1993)
  • SchwobJ.E. et al.

    Widespread patterns of neuronal damage following systemic or intracerebral injections of kainic acid: a histological study

    Neuroscience

    (1980)
  • WalkerD.G. et al.

    Complement gene expression in human brain: comparison between normal and Alzheimer disease cases

    Molec. Brain Res.

    (1992)
  • WilloughbyD.A. et al.

    Amyloid precursor protein mRNA encoding the Kunitz protease inhibitor domain is increased by kainic acid-induced seizures in rat hippocampus

    Expl Nurol.

    (1992)
  • WilsonM. et al.

    Clusterin binds by a multivalent mechanism to the Fc and Fab regions of IgG

    Biochim. biophys. Acta

    (1992)
  • ZuckerD.K. et al.

    Blood-brain barrier changes with kainic acid-induced limbic seizures

    Expl Neurol.

    (1983)
  • AngererL.M. et al.
  • ArenenderA. et al.

    Early response gene induction in astrocytes as a mechanism for encoding and integrating neuronal signals

    Prog. Brain Res.

    (1992)
  • AronowB.J. et al.

    Apolipoprotein J expression at fluid-tissue interfaces: potential role in barrier cytoprotection

  • ButtyanR. et al.

    Induction of the TRPM-2 gene in cells undergoing programmed cell death

    Molec. Cell Biol.

    (1989)
  • ChoiD.W.

    Ionic dependence of glutamate neurotoxicity

    J. Neurosci.

    (1987)
  • ChoiD.W. et al.

    Glutamate neurotoxicity in cortical cell cultures

    J. Neurosci.

    (1987)
  • ChoiN.-H. et al.

    A serum protein SP-40, 40 modulates the formation of membrane attack complex of complement on erythrocytes

    Molec. Immun.

    (1989)
  • Choi-MiuraN.H. et al.

    Identification of the disulfide bonds in human plasma protein SP-40, 40 (Apolipoprotein-J)

    J. Biochem.

    (1992)
  • CollardM.W. et al.

    Biosynthesis and molecular cloning on sulfated glycoprotein 2 secreted by rat Sertoli cells

    Biochemistry

    (1987)
  • Cited by (86)

    • Pharmacological blockade of IL-1β/IL-1 receptor type 1 axis during epileptogenesis provides neuroprotection in two rat models of temporal lobe epilepsy

      2013, Neurobiology of Disease
      Citation Excerpt :

      Considering that these pathways play a significant role in experimental seizure generation (Kharatishvili et al., 2013; Maroso et al., 2010; Sakatani et al., 2008; Shetty, 2011; Xiong et al., 2003), it is likely that their persisting activation has compensated for the IL-1β signaling blockade, therefore precluding any genuine antiepileptogenic effect. Complement upregulation may also account for cell loss in CA3 area where high level of neurotoxic C1q is induced by SE (Aronica et al., 2007; Rozovsky et al., 1994; Xiong et al., 2003). Moreover, TLRs activation per se sustains NF-kB-mediated transcription of inflammatory genes, including the IL-1β/IL-1R1 genes (O'Neill and Bowie, 2007; Vezzani et al., 2011b), likely explaining why the broad inflammatory cascade induced by SE was not affected by the combined treatment.

    • Inflammation and epilepsy

      2012, Handbook of Clinical Neurology
      Citation Excerpt :

      Among these inflammatory mediators, complement factors and COX-2 have been studied in more detail. In particular, the C1q factor of the complement cascade is upregulated by seizures in astrocytes, microglia, and neurons, and its expression is maintained in chronic epileptic tissue from animal models and human TLE (Rozovsky et al., 1994; Aronica et al., 2007). The membrane attack complex is also upregulated in microglia and surviving neurons in TLE (Aronica et al., 2007).

    • Complement in the brain

      2011, Molecular Immunology
    • THE ROLE OF THE COMPLEMENT SYSTEM IN ALZHEIMER’S DISEASE

      2023, Ankara Universitesi Eczacilik Fakultesi Dergisi
    View all citing articles on Scopus
    View full text